Description of Activities

Description: The Commission resolved to approve without conditions the acquisition by Vertice BidCo Proprietary Limited of shareholding in Vertice Medtech Holdings Proprietary Limited.

Acquiring group: The primary acquiring undertaking is Vertice BidCo Proprietary Limited, a company incorporated in terms of the laws of South Africa and engaged in the supply of pharmaceuticals, medical devices, and consumables.

Target undertaking: The primary target undertaking is Vertice Medtech Holdings Proprietary Limited, incorporated in terms of the laws of South Africa, operating as a specialized medical technology distributor and manufacturer, including specialized medical devices, healthcare products, software services, and health IT consulting; providing healthcare services, including diagnostic imaging, screening, and treatment to underserved communities through mobile units; and producing surgical drapes and distributing advanced wound care products. 

Relevant market: Concluded that it is not necessary to definitively conclude on the relevant product market definition since there are no overlaps or vertical integration between merging parties’ activities.

Merger Determination

The Commission found the proposed transaction unlikely to result in the prevention or substantial lessening of competition or result in any undertaking to acquire or strengthen a dominant position in the market and did not raise any public interest concerns.

Furthermore, as per section 50 of the Act, these approvals do not relieve parties from complying with any other mandatory statutory approvals that any of the parties to the merger must comply with under Namibian laws. Below are the summaries of the mergers determined.

Merger Determination No.1 of 2026__